Highly selective isomerization and dehydrogenation of three major bufadienolides at 3-OH by Fusarium solani

Enzyme and Microbial Technology

Volumn 40, Issue 6, 2007, Pages 1585-1591

  Ma, Xiao Chi ^a   Zheng, Jian ^b   Guo, De An ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b Biological Products   (China)

Author keywords

Biotransformation; Bufalin; Cinobufagin; Fusarium solani; Resibufogenin

Indexed keywords

BIOTRANSFORMATION; BUFALIN; FUSARIUM SOLANI; RESIBUFOGENIN;

BACTERIA; DEHYDROGENATION; FUNGI; ISOMERIZATION; PH EFFECTS; REACTION KINETICS;

HORMONES;

3 EPIBUFALIN; 3 EPIRESIBUFOGENIN; 3 KETOCINOBUFAGIN; BUFADIENOLIDE DERIVATIVE; BUFALIN; BUFOGENIN; CINOBUFAGIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; CHEMICAL REACTION KINETICS; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY TEST; DEHYDROGENATION; DRUG DETERMINATION; DRUG STRUCTURE; FEMALE; FUSARIUM SOLANI; HUMAN; HUMAN CELL; IC 50; ISOMERIZATION; PH;

FUNGI; FUSARIUM SOLANI;

EID: 33947599064     PISSN: 01410229     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.enzmictec.2006.11.015     Document Type: Article

References (25)

1. Chen Y., Xiang J., Gu W., and Xu M. Chemical constituents of Bufo siccus. China J Chin Mater Med 23 (1998) 620-621
2. Xie J.T., Dey L., Wu J.A., Lowell T.K., and Yuan C.S. Cardiac toxicity of resibufogenin: electrophysiological evidence. Acta Pharmacol Sin 22 (2001) 289-297
3. Nogawa T., Kamano Y., Yamashita A., and Pettit P.T. Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Chan Su. J Nat Prod 64 (2001) 1148-1152
4. Terness P., Navolan D., Dufter C., Kopp B., and Opelz G. The T-cell suppressive effect of bufadienolides: structural requirements for their immunoregulatory activity. Int Immunpharmacol 1 (2001) 119-134
5. Krenn L., and Kopp B. Bufadienolides from animal and plant sources. Phytochemistry 48 (1998) 1-29
6. Steyn P.S., and Heerden F.R. Bufadienolides of plant and animal origin. Nat Prod Rep 15 (1998) 397-413
7. Zhang L.S., Nakaya K., Yoshida T., and Kuroiwa Y. Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 178 (1991) 686-693
8. Zhang L.S., Nakaya K., Yoshida T., and Kuroiwa Y. Induction by bufalin of differentiation of human leukemia cells HL60, U937 and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res 52 (1992) 4634-4641
9. Hashimoto S., Jing Y., Kawazoe N., Masuda Y., Nakajo S., Yoshida T., et al. Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leukemia Res 21 (1997) 875-883
10. Riva S. Biocatalytic modification of natural products. Curr Opin Chem Biol 5 (2001) 106-111
11. Abourashed E.A., Clark A.M., and Hufford C.D. Microbial models of mammalian metabolism of xenobiotics: an updated review. Curr Med Chem 6 (1999) 359-374
12. Ye M., Qu G., Guo H., and Guo D.A. Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships. J Steroid Biochem Biol 91 (2004) 87-98
13. Ye M., Qu G., Guo H., and Guo D.A. Specific 12β-hydroxylation of cinobufagin by filamentous fungi. Appl Environ Microbiol 70 (2004) 3521-3527
14. Ye M., and Guo D.A. Substrate specificity for the 12β-hydroxylation of bufadienolides by Alternaria alternata. J Biotechnol 117 (2005) 253-262
15. Ye M., Han J., Tu G.Z., An D.G., and Guo D.A. Microbial hydroxylation of bufalin. J Nat Prod 68 (2005) 626-628
16. Ye M., Dai J., and Guo D.A. Glucosylation of cinbufagin by cultured suspension cells of Catharanthus roseus. Tetrahedron Lett 43 (2002) 8535-8538
17. Zhan J.X., Liu W., Guo H., and Guo D.A. Selective dehydrogenation of resibufogenin and cinobufagin at 3-OH by Pseudomoas aeruginosa. Enzyme Microb Technol 33 (2003) 29-32
18. Ma X.C., Ye M., Wu L.J., and Guo D.A. Microbial transformation of curdione by Mucor spinosus. Enzyme Microb Technol 38 (2006) 367-371
19. Li L., Li P., Ye M., and Guo D. Cytotoxic resibufogenin transformation products from cell suspension cultures of Platgcodon grandiflorum. Lett Org Chem 1 (2004) 176-178
20. Toma S., Hirai Y., and Sugimoto C. Metabolic fate of bufalin and cinobufagin. Yakugaku Zasshi 111 (1991) 687-694
21. Zhang L.S., Yoshida T., Aoki K., and Kuroiwa Y. Metabolism of cinobufagin in rat liver microsomes. Identification of epimerized and deacetylated metabolites by liquid chromatography/mass spectrometry. Drug Metab Dispos 19 (1991) 917-919
22. Bernhardt R. Cytochromes P450 as versatile biocatalysts. J Biotechnol 124 (2006) 128-145
23. Bernhardt R. Cytochromes P450. Encyclopedia Biol Chem 1 (2004) 544-549
24. Sakamaki H., Itoh K.I., Chai W., Hayashida Y., and Horiuchi C.A. Biotransformation of (±)-α-ionone and β-ionone by cultured cells of Caragana chanmlagu. J Mol Catal B: Enzymatic 27 (2004) 177-181
25. Hashimoto T., Noma Y., and Asakawa Y. Biotransformation of terpenoids from the crude drugs and animal origin by microorganism. Heterocycles 54 (2004) 529-559